Optimal management of symptomatic malignant pleural effusions remains an important issue as it affects a significant number of patients each year internationally. The overall survival remains poor, necessitating an evidence based treatment strategy that provides the best outcomes for individual patients. This paper summarises the results of the recently published Cochrane review on interventions in malignant pleural effusions.
No takes yet. Share an insight, caveat, or question.
Clive et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: